Correlation Between COSCIENS Biopharma and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both COSCIENS Biopharma and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining COSCIENS Biopharma and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between COSCIENS Biopharma and Candel Therapeutics, you can compare the effects of market volatilities on COSCIENS Biopharma and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in COSCIENS Biopharma with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of COSCIENS Biopharma and Candel Therapeutics.
Diversification Opportunities for COSCIENS Biopharma and Candel Therapeutics
0.86 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between COSCIENS and Candel is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding COSCIENS Biopharma and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and COSCIENS Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on COSCIENS Biopharma are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of COSCIENS Biopharma i.e., COSCIENS Biopharma and Candel Therapeutics go up and down completely randomly.
Pair Corralation between COSCIENS Biopharma and Candel Therapeutics
Given the investment horizon of 90 days COSCIENS Biopharma is expected to under-perform the Candel Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, COSCIENS Biopharma is 3.62 times less risky than Candel Therapeutics. The stock trades about -0.12 of its potential returns per unit of risk. The Candel Therapeutics is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 465.00 in Candel Therapeutics on September 12, 2024 and sell it today you would earn a total of 310.00 from holding Candel Therapeutics or generate 66.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
COSCIENS Biopharma vs. Candel Therapeutics
Performance |
| Timeline |
| COSCIENS Biopharma |
| Candel Therapeutics |
COSCIENS Biopharma and Candel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with COSCIENS Biopharma and Candel Therapeutics
The main advantage of trading using opposite COSCIENS Biopharma and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if COSCIENS Biopharma position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.| COSCIENS Biopharma vs. Equillium | COSCIENS Biopharma vs. DiaMedica Therapeutics | COSCIENS Biopharma vs. Valneva SE ADR | COSCIENS Biopharma vs. Vivani Medical |
| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |